These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 19807761

  • 21. Efficacy and safety of injection with poly-L-lactic acid compared with hyaluronic acid for correction of nasolabial fold: a randomized, evaluator-blinded, comparative study.
    Hyun MY, Lee Y, No YA, Yoo KH, Kim MN, Hong CK, Chang SE, Won CH, Kim BJ.
    Clin Exp Dermatol; 2015 Mar; 40(2):129-35. PubMed ID: 25319932
    [Abstract] [Full Text] [Related]

  • 22. Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring.
    Lam SM, Azizzadeh B, Graivier M.
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):55S-63S. PubMed ID: 16936545
    [Abstract] [Full Text] [Related]

  • 23. Granulomatous foreign body reaction to hyaluronic acid: report of a case after melolabial fold augmentation and review of management.
    Sage RJ, Chaffins ML, Kouba DJ.
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1696-700. PubMed ID: 19807766
    [No Abstract] [Full Text] [Related]

  • 24. Soft-tissue augmentation and the role of poly-L-lactic acid.
    Vleggaar D.
    Plast Reconstr Surg; 2006 Sep; 118(3 Suppl):46S-54S. PubMed ID: 16936544
    [Abstract] [Full Text] [Related]

  • 25. Adverse effects of fillers and their histopathology.
    Haneke E.
    Facial Plast Surg; 2014 Dec; 30(6):599-614. PubMed ID: 25536126
    [Abstract] [Full Text] [Related]

  • 26. Dermal fillers and combinations of fillers for facial rejuvenation.
    Beer K.
    Dermatol Clin; 2009 Oct; 27(4):427-32, v. PubMed ID: 19850192
    [Abstract] [Full Text] [Related]

  • 27. Safety of nonanimal stabilized hyaluronic acid dermal fillers in patients with skin of color: a randomized, evaluator-blinded comparative trial.
    Taylor SC, Burgess CM, Callender VD.
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1653-60. PubMed ID: 19807760
    [Abstract] [Full Text] [Related]

  • 28. Electron microscopic documentation of late changes in permanent fillers and clinical management of granulomas in affected patients.
    Wiest LG, Stolz W, Schroeder JA.
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1681-8. PubMed ID: 19807764
    [Abstract] [Full Text] [Related]

  • 29. Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers.
    Christensen LH.
    Dermatol Surg; 2009 Oct; 35 Suppl 2():1612-9. PubMed ID: 19807755
    [Abstract] [Full Text] [Related]

  • 30. Volume rejuvenation of the facial upper third.
    Buckingham ED, Glasgold R, Kontis T, Smith SP, Dolev Y, Fitzgerald R, Lam SM, Williams EF, Pollei TR.
    Facial Plast Surg; 2015 Feb; 31(1):43-54. PubMed ID: 25763896
    [Abstract] [Full Text] [Related]

  • 31. NewFill for skin augmentation: a new filler or failure?
    Burgess CM, Lowe NJ.
    Dermatol Surg; 2006 Dec; 32(12):1530-2; author reply 1532. PubMed ID: 17199668
    [No Abstract] [Full Text] [Related]

  • 32. Collagen Stimulators: Poly-L-Lactic Acid and Calcium Hydroxyl Apatite.
    Breithaupt A, Fitzgerald R.
    Facial Plast Surg Clin North Am; 2015 Nov; 23(4):459-69. PubMed ID: 26505542
    [Abstract] [Full Text] [Related]

  • 33. Late-onset immune-mediated adverse effects after poly-L-lactic acid injection in non-HIV patients: clinical findings and long-term follow-up.
    Alijotas-Reig J, Garcia-Gimenez V, Vilardell-Tarres M.
    Dermatology; 2009 Nov; 219(4):303-8. PubMed ID: 19797889
    [Abstract] [Full Text] [Related]

  • 34. Persistent granulomatous inflammatory response induced by injectable poly-L-lactic acid for HIV lipoatrophy.
    Wildemore JK, Jones DH.
    Dermatol Surg; 2006 Nov; 32(11):1407-9; discussion 1409. PubMed ID: 17083596
    [No Abstract] [Full Text] [Related]

  • 35. Facial dermal fillers.
    Fitzgerald R, Vleggaar D, Burgess C.
    Aesthet Surg J; 2008 Nov; 28(6):699-701; author reply 701. PubMed ID: 19083602
    [No Abstract] [Full Text] [Related]

  • 36. Adverse reactions caused by consecutive injections of different fillers in the same facial region: risk assessment based on the results from the Injectable Filler Safety study.
    Bachmann F, Erdmann R, Hartmann V, Becker-Wegerich P, Wiest L, Rzany B.
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):902-12. PubMed ID: 21054567
    [Abstract] [Full Text] [Related]

  • 37. Facial volume augmentation in 2014: overview of different filler options.
    Luebberding S, Alexiades-Armenakas M.
    J Drugs Dermatol; 2013 Dec; 12(12):1339-44. PubMed ID: 24301234
    [Abstract] [Full Text] [Related]

  • 38. Satisfying patient expectations with soft-tissue augmentation.
    Mandy SH.
    Dermatol Online J; 2009 Jul 15; 15(7):1. PubMed ID: 19903429
    [Abstract] [Full Text] [Related]

  • 39. Facial Soft-Tissue Fillers: Assessing the State of the Science conference---Proceedings report.
    Hanke CW, Rohrich RJ, Busso M, Carruthers A, Carruthers J, Fagien S, Fitzgerald R, Glogau R, Greenberger PE, Lorenc ZP, Marmur ES, Monheit GD, Pusic A, Rubin MG, Rzany B, Sclafani A, Taylor S, Weinkle S, McGuire MF, Pariser DM, Casas LA, Collishaw KJ, Dailey RA, Duffy SC, Edgar EJ, Greenan BL, Haenlein K, Henrichs RA, Hume KM, Lum F, Nielsen DR, Poulsen L, Shoaf L, Seward W, Begolka WS, Stanton RG, Svedman KJ, Thomas JR, Sykes JM, Wargo C, Weiss RA.
    J Am Acad Dermatol; 2011 Apr 15; 64(4 Suppl):S53-65. PubMed ID: 21458678
    [Abstract] [Full Text] [Related]

  • 40. Facial dermal fillers: selection of appropriate products and techniques.
    Dayan SH, Bassichis BA.
    Aesthet Surg J; 2008 Apr 15; 28(3):335-47. PubMed ID: 19083546
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.